|Issuer:||AADI BIOSCIENCE, INC. (AADI)|
|Original Submission Date:|
C/O AADI BIOSCIENCE, INC.
17383 SUNSET BOULEVARD, SUITE A250 PACIFIC PALISADES, CA 90272
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|STOCK OPTION (RIGHT TO BUY)||12.31||2023-01-03||deemed execution date||A||150,000 (a)||2033-01-03||common stock 150,000||$12.31||150,000||direct|
|f1||subject to the reporting person continuing to be a service provider (as defined in the issuer's 2021 equity incentive plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the vesting commencement date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the vesting commencement date. "vesting commencement date" shall mean january 1, 2023.|